Tiger Brokers

  • Markets
    • Quotes
    • 24/7 News
  • Products
    • Cash Boost Account
    • Options
    • China A-shares
    • HK Stocks
    • Fixed Coupon Notes
    • US Stocks
    • ETFs
    • Funds
    • US Treasury
    • Singapore Stocks
    • Futures
    • Tiger BOSS Debit Card
    • Tiger Vault
  • Features
    • Tiger Investment Representatives
    • Auto-invest
    • Invest with CPF/SRS
    • Learn
    • US Fractional Shares
  • TigerAI
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Statement
      • Statement
      • Dividends
  • Institution
    • Tiger Fund Management
    • Institution Service
      • Wealth and asset manager
      • Proprietary trading institutions
      • Introducing brokers
      • Third-party service provider
    • Tiger Open Platform
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

ProQR Therapeutics NV

2.43
+0.09003.85%
Post-market: 2.430.00000.00%18:39 EDT
Volume:1.06M
Turnover:2.54M
Market Cap:342.92M
PE:-5.31
High:2.46
Open:2.35
Low:2.26
Close:2.34
52wk High:3.10
52wk Low:1.33
Shares:141.12M
Float Shares:101.18M
Volume Ratio:0.81
T/O Rate:1.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4578
EPS(LYR):-0.4702
ROE:-57.40%
ROA:-19.76%
PB:3.70
PE(LYR):-5.17

Loading ...

OverviewCompanyNewsFilings

ProQR Therapeutics NV files Form 3 initial beneficial ownership statement for Director Shannon James Samuel

Reuters
·
Mar 19

ProQR Therapeutics Q4 Net Loss Of €8.9 Million Reinforces Profitability Concerns

Simply Wall St.
·
Mar 14

ProQR Therapeutics Faces Heightened Activist Investor Pressure and Governance Uncertainty

TIPRANKS
·
Mar 13

ProQR Therapeutics NV reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 12

ProQR FY 2025 net loss rises 52% to EUR 42.2 million as cash falls 38% to EUR 92.4 million

Reuters
·
Mar 12

ProQR Announces Year End 2025 Operating and Financial Results

THOMSON REUTERS
·
Mar 12

ProQR Therapeutics NV expected to post a loss of 10 cents a share - Earnings Preview

Reuters
·
Mar 09

ProQR Therapeutics to Present at Citizens Life Sciences Conference

Reuters
·
Mar 04

Analyst Rate

Buy
Buy
100.00%
Hold
0.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Aug 13, 2026 Pre-MKt
Financial Report Announcement
May 12, 2026 Pre-MKt
Financial Report Announcement
Mar 12, 2026 Pre-MKt
Financial Report Announcement
Nov 06, 2025 Pre-MKt
Financial Report Announcement
Aug 07, 2025 Pre-MKt

Dividend History

no data

No relevant data is available

Valuation Analysis

-5.26
Current
-4.57
Sector Average
20.10%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-5.26
Maximum
-0.67
+1 STD
-1.44
Minimum
-16.15
-1 STD
-7.69
Average
-4.57

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.